Dr. Philip M. Ginsburg, MD

Dr. Ginsburg practices at Endoscopy Center of Connecticut in Hamden, Connecticut.

Dr. Ginsburg's NPI, 1679554539, was assigned on November 8, 2005. Dr. Ginsburg holds Connecticut license 043205.

Dr. Ginsburg's primary practice is Endoscopy Center of Connecticut, at 2200 Whitney Avenue, Suite 380, Hamden, CT 06518. The practice phone is (203) 281-3636.

Dr. Ginsburg's primary practice is Endoscopy Center of Connecticut in Hamden, Connecticut. Dr. Ginsburg is also affiliated with Rutland Regional Medical Center. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Ginsburg to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ginsburg practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ginsburg's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ginsburg is licensed in Connecticut.

CMS data shows 34,652 Medicare services from Dr. Ginsburg across 14 procedure codes in 2024, for 170 Medicare patients. Medicare paid $672,724 for them.

CMS counts 170 Medicare patients who saw Dr. Ginsburg in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ginsburg's median patient age at 57, with 50% women.

In 2024, Dr. Ginsburg wrote 746 Medicare Part D claims for 160 patients. 72% of them were for generic drugs. CMS names the drug for 577 of them, across 21 drugs with 11 or more claims each, at $2,288,473 in total drug cost. In 2023, CMS named 627 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ginsburg for performance year 2024, reported through an alternative payment model (APM). Dr. Ginsburg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 111 procedures of colonoscopy by Dr. Ginsburg, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Ginsburg, published from 2015 to 2024. Dr. Ginsburg's most frequent co-authors are Francis A. Farraye, MD, David G. Binion, MD and Matthew E. Bohm, MD.

Dmand AI links Dr. Ginsburg to 9 clinical trials. 2 are still active or recruiting. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Colitis, Ulcerative. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Ginsburg that name 6 trials.

CMS Open Payments shows 723 general payments to Dr. Ginsburg from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Abbvie Inc. paid the most, $386,725. It also lists 12 research payments totaling $21,766 from 2016 to 2023, naming 6 clinical trials.